Psychiatry and Neurology, Neurology · St Louis Park, MN
NPI
1013054386
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3931 Louisiana Ave. S. Suite E500
St Louis Park, MN, 55426
Phone (952) 993-3200
Groups this clinician bills Medicare through
Medicare paid, 2024
$119K
10,577 services
Medicare patients, 2024
446
Average age 75
Drug cost, 2024
$1.3M
5,719 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel Kuyper was code J0585 (injection, onabotulinumtoxina, 1 unit), 9,150 times for 13 patients. In total Daniel Kuyper billed 10,577 services in 32 codes, and Medicare paid $119K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-01-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 9,150 | 13 | $4.98 | $46K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 215 | 161 | $11.81 | $2,540 |
| 99214 Office E&M - Established | Facility | 173 | 120 | $61.00 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 167 | 129 | $12.35 | $2,063 |
| 99214 Office E&M - Established | Office | 163 | 130 | $87.13 | $14K |
| 99215 Office E&M - Established | Facility | 103 | 79 | $90.47 | $9,319 |
| 99204 Office E&M - New | Office | 70 | 70 | $113.87 | $7,971 |
| 99215 Office E&M - Established | Office | 67 | 57 | $116.25 | $7,789 |
| 36415 Venipuncture Blood Collection | Office | 30 | 24 | $8.65 | $260 |
| 99204 Office E&M - New | Facility | 26 | 26 | $81.30 | $2,114 |
| 99205 Office E&M - New | Facility | 16 | 16 | $118.52 | $1,896 |
By year: 2022 $120K for 10,397 services; 2023 $114K for 10,235 services; 2024 $119K for 10,577 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 30 | 24 | $8.65 | $260 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Kuyper prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 1,820 prescriptions and refills. In total Daniel Kuyper wrote 5,719 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,820 | 4,247 | 461 | $119K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 520 | 1,295 | 144 | $35K |
| Donepezil Hcl Generic | 363 | 861 | 105 | $5,919 |
| Amantadine Amantadine Hcl | 212 | 509 | 60 | $11K |
| Levetiracetam Generic | 199 | 438 | 48 | $8,849 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 197 | 499 | 51 | $6,130 |
| Gabapentin Generic | 196 | 462 | 62 | $4,479 |
| Primidone Generic | 183 | 458 | 54 | $7,032 |
| Quetiapine Fumarate Generic | 144 | 218 | 41 | $1,989 |
| Rytary Carbidopa/Levodopa | 135 | 269 | 25 | $264K |
| Clonazepam Generic | 111 | 214 | 26 | $1,466 |
| Entacapone Generic | 103 | 170 | 20 | $25K |
| Propranolol Hcl Generic | 91 | 252 | 27 | $3,074 |
| Ropinirole Hcl Generic | 75 | 208 | 22 | $3,552 |
| Midodrine Hcl Generic | 71 | 135 | 15 | $4,540 |
Brand drugs: 260 claims; generic drugs: 5,445 claims; opioid claims: 16.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Daniel Kuyper were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.